Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sucrose octasulfate is a highly sulfated polyanionic derivative of sucrose. It is most recognized as the active therapeutic component of sucralfate, an anti-ulcer medication where it is complexed with aluminum hydroxide. As a standalone molecule, sucrose octasulfate exhibits potent mucosal protective properties by binding to and stabilizing various growth factors, such as fibroblast growth factors (FGFs), which facilitates tissue repair and angiogenesis. It also stimulates the release of somatostatin from gastric D cells, contributing to its gastroprotective profile. Beyond its direct therapeutic applications, sucrose octasulfate (often as a potassium or sodium salt) is utilized as a novel pharmaceutical excipient in liposomal formulations. In this role, it acts as a trapping agent to enable the efficient loading and stabilization of weakly basic drugs through the formation of intra-liposomal precipitates.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sucrose octasulfate.